Psilocybin-facilitated Treatment for Chronic Pain

EARLY_PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 1, 2023

Primary Completion Date

August 1, 2026

Study Completion Date

August 1, 2026

Conditions

Fibromyalgia, Primary

Interventions

DRUG

Psilocybin

0.36 mg/kg will be administered orally to participants

DRUG

Dextromethorphan

2.6 mg/kg of active placebo will be administered orally to participants

Trial Locations (1)

RECRUITING

UAB Beacon Tower, Birmingham

All Listed Sponsors

lead

University of Alabama at Birmingham

OTHER